☆Davern Capital Partners, LP
Quality Q
0.395
AUM ($M)
587
Positions
15
Turnover
0.33
Top-10 wt
87%
Herfindahl
0.087
History (qtrs)
3
Excess Return
—
AI Eval Run AI Eval
Holdings · 20 positions · portfolio value $587M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆BNTX funds › | BIONTECH SE | ADD | — | 12.0% | +4.5% | 70.2 | 754,550 | +449,495 | 2 | — |
| ☆CUSIP:G76279101 funds › | ROIVANT SCIENCES LTD | ADD | — | 11.7% | +5.0% | 68.4 | 1,932,904 | +1,059,506 | 2 | — |
| ☆RPRX funds › | ROYALTY PHARMA PLC | ADD | — | 11.0% | +4.2% | 64.8 | 1,155,809 | +635,800 | 2 | — |
| ☆IONS funds › | IONIS PHARMACEUTICALS INC | ADD | — | 10.8% | +2.8% | 63.3 | 798,709 | +411,806 | 2 | — |
| ☆INSM funds › | INSMED INC | ADD | — | 10.2% | +2.0% | 59.7 | 559,824 | +377,262 | 2 | — |
| ☆REGN funds › | REGENERON PHARMACEUTICALS | ADD | — | 9.8% | +0.4% | 57.8 | 92,640 | +47,840 | 2 | — |
| ☆LEGN funds › | LEGEND BIOTECH CORP | TRIM | — | 5.9% | -0.7% | 34.4 | 1,191,522 | -123,226 | 2 | — |
| ☆ALNY funds › | ALNYLAM PHARMACEUTICALS INC | NEW | — | 5.8% | +5.8% | 34.0 | 113,085 | +113,085 | 1 | — |
| ☆NTRA funds › | NATERA INC | TRIM | — | 5.5% | -2.4% | 32.3 | 118,975 | -24,991 | 2 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | ADD | — | 4.1% | +2.4% | 23.9 | 446,059 | +319,598 | 2 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | ADD | — | 4.0% | +0.6% | 23.2 | 858,753 | +411,600 | 2 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | NEW | — | 3.6% | +3.6% | 21.4 | 498,832 | +498,832 | 1 | — |
| ☆GENB funds › | GENERATE BIOMEDICINES INC | ADD | — | 2.4% | +0.3% | 13.9 | 824,679 | +232,879 | 2 | — |
| ☆PRCT funds › | PROCEPT BIOROBOTICS CORP | ADD | — | 1.8% | -0.0% | 10.5 | 464,920 | +203,720 | 2 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | NEW | — | 1.5% | +1.5% | 8.7 | 468,666 | +468,666 | 1 | — |
| ☆PFE funds › | PFIZER INC | EXIT | — | 0.0% | -12.3% | 0.0 | 0 | -1,593,942 | 0 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | EXIT | — | 0.0% | -1.6% | 0.0 | 0 | -302,457 | 0 | — |
| ☆ARGX funds › | ARGENX SE | EXIT | — | 0.0% | -7.0% | 0.0 | 0 | -35,045 | 0 | — |
| ☆ABVX funds › | ABIVAX SA | EXIT | — | 0.0% | -2.4% | 0.0 | 0 | -78,125 | 0 | — |
| ☆LLY funds › | ELI LILLY & CO | EXIT | — | 0.0% | -6.9% | 0.0 | 0 | -27,279 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 587 | 15 | 0.33 | 87% | 0.087 | 0.396 | — | in |
| 2026Q1 | 365 | 17 | 0.23 | 81% | 0.075 | 0.495 | — | entered |
| 2025Q4 | 309 | 14 | 0.00 | 91% | 0.099 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status